Lewis & Faye Manderson Cancer Center at DCH Regional Medical Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dubay, John
OMNIA-1, NCT05578872 / 2021-006711-29: A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma ().

Completed
1/2
29
Europe, US
ANV419
Anaveon AG, Anaveon AG
Melanoma (Skin), Cutaneous Melanoma, Adult Disease, Advanced Solid Tumor, Metastatic Melanoma
08/24
08/24
INSIGHT, NCT03289780: Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

Active, not recruiting
N/A
5006
US
Biodesix, Inc.
Non-Small Cell Lung Cancer
12/25
12/25
Daniel, Danielle
INSIGHT, NCT03289780: Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

Active, not recruiting
N/A
5006
US
Biodesix, Inc.
Non-Small Cell Lung Cancer
12/25
12/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dubay, John
OMNIA-1, NCT05578872 / 2021-006711-29: A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma ().

Completed
1/2
29
Europe, US
ANV419
Anaveon AG, Anaveon AG
Melanoma (Skin), Cutaneous Melanoma, Adult Disease, Advanced Solid Tumor, Metastatic Melanoma
08/24
08/24
INSIGHT, NCT03289780: Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

Active, not recruiting
N/A
5006
US
Biodesix, Inc.
Non-Small Cell Lung Cancer
12/25
12/25
Daniel, Danielle
INSIGHT, NCT03289780: Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

Active, not recruiting
N/A
5006
US
Biodesix, Inc.
Non-Small Cell Lung Cancer
12/25
12/25

Download Options